Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.19 USD | +0.81% | -5.87% | +28.58% |
Financials (USD)
Sales 2024 * | 378M | Sales 2025 * | 446M | Capitalization | 2.28B |
---|---|---|---|---|---|
Net income 2024 * | -97M | Net income 2025 * | 30M | EV / Sales 2024 * | 5.45 x |
Net cash position 2024 * | 219M | Net cash position 2025 * | 338M | EV / Sales 2025 * | 4.35 x |
P/E ratio 2024 * |
-37.2
x | P/E ratio 2025 * |
79.1
x | Employees | 1,008 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.14% |
Latest transcript on Cellebrite DI Ltd.
1 day | -6.57% | ||
1 week | -5.85% | ||
Current month | +2.68% | ||
1 month | +2.02% | ||
3 months | -6.33% | ||
6 months | +31.52% | ||
Current year | +28.18% |
Managers | Title | Age | Since |
---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 03-12-31 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 14-05-06 |
Ayala Shapira
CMP | Compliance Officer | 53 | 22-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 21-08-29 |
Thomas Hogan
CHM | Chairman | 64 | 23-08-07 |
Dafna Gruber
BRD | Director/Board Member | 58 | 21-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +5.87% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 11.15 | +0.45% | 401 164 |
24-05-24 | 11.1 | -6.57% | 2,410,765 |
24-05-23 | 11.88 | +2.33% | 2,000,181 |
24-05-22 | 11.61 | -1.86% | 937,121 |
24-05-21 | 11.83 | +0.34% | 575,614 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.18% | 2.28B | |
+14.39% | 3,197B | |
+14.08% | 89.6B | |
+8.04% | 80.08B | |
-12.51% | 55.52B | |
+22.36% | 46.79B | |
+31.67% | 46.34B | |
-29.01% | 43.95B | |
+77.73% | 41.34B | |
-3.95% | 26.5B |
- Stock Market
- Equities
- CLBT Stock